B2B Hemp Consumables Distributor, $52M Revenue Wholesaler

$51.8M

Revenue

$9.1M

SDE

4.1x

Multiple

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a B2B wholesale and distribution operation moving legalized low-dose hemp consumables across state lines. The revenue mix is heavily weighted toward other distributors: 59% flows to smaller wholesalers, 38% goes B2B to multi-location shop owners, and under 3% is sold direct to consumers (and that sliver is intentional, used for R&D). Services span wholesale, coordinating manufacturing, packaged development with fulfillment, and arranging third-party freight, meaning the company carries no drivers or trucks of its own.

The business runs out of a 12,000 sq. ft. facility in Orange County, California that it upgraded in 2022 for growth, plus a second distribution center added in Florida in 2023 to keep pace with demand. A 39-person team runs it: a CFO, General Manager, VP of Sales, Retail Lead, two Manufacturing Leads, a Warehouse Lead, four warehouse associates, five in-house sales reps, 24 packagers, and 19 outside sales reps. That is a real management layer, not a one-person show.

The product sits in a legally gray but fast-expanding niche. The company sells regulated hemp (not traditional cannabis), which currently enjoys legal status in 36 states with another 7 projected to follow in 6-9 months. At $52M revenue and $9.1M cash flow, the margin profile is genuinely strong, but the entire thesis rides on a regulatory framework that can shift state by state or federally with little warning.

Why we like it

Earnings quality is real on paper: $9.1M of cash flow on $52M of revenue is a ~17.6% margin, which is excellent for a distribution business where mid-single-digit margins are the norm. The 4.07x multiple on cash flow looks cheap until you account for the regulatory tail risk, which is precisely why it is priced where it is.
The seller alignment is the single best feature of this deal. The owner will stay 4-5 years and is offering a 35% carry or equity roll, which puts meaningful skin in the game and signals they are not simply dumping a business ahead of a regulatory cliff.
The company is asset-light by design: no trucks, no drivers, freight fully outsourced, operating from two leased facilities. This keeps capital requirements low and makes the business genuinely relocatable, which is valuable optionality if a given state's rules change.
There is a visible demand tailwind as more states legalize low-dose hemp consumables, with 36 states today and 7 more projected in the near term. Selling regulated hemp rather than traditional cannabis is what lets this business ship across state lines, a structural advantage over state-locked cannabis operators.

How to improve it

Bring manufacturing in house, which the listing itself flags as the top growth lever. Capturing the manufacturing margin on products you already distribute would lift blended margins and reduce dependence on third-party coordinating partners inside the first year.
Build a compliance and regulatory-affairs function immediately. Given 36 states in and 7 pending, a dedicated legal/regulatory lead tracking each state's hemp rules protects the revenue base and turns regulatory agility into a competitive moat.
Diversify customer concentration away from the 59% that flows through other wholesalers. Those intermediaries can be disintermediated or squeezed on price, so pushing more volume directly to the 38% multi-location shop channel would improve both margin and pricing power.
Introduce contract or standing-order programs with the largest multi-location buyers to create recurring, predictable revenue. Today this reads as transactional wholesale; even quarterly supply agreements would smooth cash flow and increase enterprise value at exit.
Tighten and document SKU-level unit economics across the product line. With 24 packagers and in-house packaged development, there is likely margin to reclaim by rationalizing low-velocity SKUs and renegotiating input costs at current scale.
Formalize a second-source supply chain for key inputs. A business this exposed to raw hemp availability and regulatory shifts needs redundancy so a single supplier or state-level disruption does not stall fulfillment.
Invest in brand and R&D using the intentional sub-3% direct-to-consumer channel as a testing ground. Proven DTC winners can then be pushed through the wholesale network at higher margin, turning a research cost center into a product pipeline.

Diligence notes

Regulatory risk is the entire deal. Verify the exact legal status of the low-dose hemp products in each of the 36 claimed states, confirm the 7 pending states are real pipeline and not optimism, and stress-test what happens to revenue if the federal Farm Bill framework or state DSHEA-style rules tighten. A single adverse federal ruling could impair a large share of this business.
Scrutinize the quality of the $9.1M cash flow figure. SDE at this size blends owner comp and add-backs, so demand audited or reviewed financials, a full add-back schedule, and bank statements to confirm the margin is sustainable and not propped up by one-time or aggressive adjustments.
Examine customer concentration and payment terms. With 97% of revenue B2B and 59% through other wholesalers, identify how much comes from the top 5-10 accounts, their credit quality, and whether any single buyer or channel loss would materially dent cash flow.
Confirm banking, payment processing, and insurance arrangements. Hemp-adjacent businesses frequently face banking access, processor, and insurance challenges; losing a banking relationship or facing uninsurable product liability would be a serious operational hit.
Validate the inventory and supply chain. Understand input sourcing, shelf life of consumables, inventory valuation included in the sale, and exposure to raw hemp price swings or supplier concentration that could squeeze the attractive margin.
Pressure-test the owner's 4-5 year commitment and the 35% carry structure in writing. Clarify what decisions the rolling owner controls, how the carry is valued and triggered, and what product-development and relationship knowledge walks out the door if the transition ends early.

Source

Originally listed on BizBuySell. View original listing →